N. U. DOĞAN Et Al. , "Anti-Mullerian hormone is associated with extrauterine involvement and stage of disease in patients with endometrial cancer," JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.35, no.2, pp.178-182, 2015
DOĞAN, N. U. Et Al. 2015. Anti-Mullerian hormone is associated with extrauterine involvement and stage of disease in patients with endometrial cancer. JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.35, no.2 , 178-182.
DOĞAN, N. U., Kerimoglu, O. S., Karabagli, P., Pekin, A., Yilmaz, S. A., Incesu, F., ... Celik, C.(2015). Anti-Mullerian hormone is associated with extrauterine involvement and stage of disease in patients with endometrial cancer. JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.35, no.2, 178-182.
DOĞAN, NASUH Et Al. "Anti-Mullerian hormone is associated with extrauterine involvement and stage of disease in patients with endometrial cancer," JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.35, no.2, 178-182, 2015
DOĞAN, NASUH U. Et Al. "Anti-Mullerian hormone is associated with extrauterine involvement and stage of disease in patients with endometrial cancer." JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.35, no.2, pp.178-182, 2015
DOĞAN, N. U. Et Al. (2015) . "Anti-Mullerian hormone is associated with extrauterine involvement and stage of disease in patients with endometrial cancer." JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.35, no.2, pp.178-182.
@article{article, author={NASUH UTKU DOĞAN Et Al. }, title={Anti-Mullerian hormone is associated with extrauterine involvement and stage of disease in patients with endometrial cancer}, journal={JOURNAL OF OBSTETRICS AND GYNAECOLOGY}, year=2015, pages={178-182} }